Fig. 3From: Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancerAssay-to-Assay Comparison for Antibody-Based Technologies. a Myriad-RBM estimates higher absolute protein concentration in comparison to Olink platform. b Protein levels are concordant for most proteins measured in both antibody-based platformsBack to article page